Ardelyx
ARDX
$6.90
Share price
2.22%
Change (1 day)
111.01%
Change (1 year)
Categories
Market capitalization of Ardelyx (ARDX)
Market cap: $1.61 Billion
As of May 2024 Ardelyx has a market cap of $1.61 Billion. This makes Ardelyx the world's 4503th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Ardelyx from 2014 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $1.61 B | 12.17% |
| 2023 | $1.43 B | 169.39% |
| 2022 | $0.53 B | 330.79% |
| 2021 | $0.12 B | -79.52% |
| 2020 | $0.60 B | -9.15% |
| 2019 | $0.66 B | 495.66% |
| 2018 | $0.11 B | -64.33% |
| 2017 | $0.31 B | -53.29% |
| 2016 | $0.67 B | 42.77% |
| 2015 | $0.47 B | 33.98% |
| 2014 | $0.35 B |
End of Day market cap according to different sources
On May 28th, 2024 the market cap of Ardelyx was reported to be:
$1.61 Billion
$1.61 Billion
$1.61 Billion
$1.60 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Abbott Laboratories ABT | $177.35 B | 10,885.55% | 🇺🇸 USA |
 Amgen AMGN | $161.03 B | 9,874.50% | 🇺🇸 USA |
 Sanofi SNY | $121.88 B | 7,449.73% | 🇫🇷 France |
 AstraZeneca AZN | $241.98 B | 14,888.88% | 🇬🇧 UK |
 OPKO Health
OPK | $0.94 B | -41.29% | 🇺🇸 USA |